Rocket Lab USA Inc. saw its shares decline significantly in premarket trading Thursday after the space technology company disclosed plans to sell up to $3 billion of common stock through an at-the-market offering program. The filing, submitted late Wednesday, comes at a pivotal moment for the sector as SpaceX officially filed for its long-awaited initial public offering, introducing a new valuation benchmark for space-related companies.
Shares of Rocket Lab were quoted at approximately $126.75 in early trading, down from Wednesday's closing price of $134.28. The decline represents a reversal of what had been a strong 2026 rally, with the stock up roughly 92% year-to-date before the announcement. The premarket session on Nasdaq runs from 4:00 a.m. to 9:30 a.m. Eastern time, with regular trading scheduled to open at 9:30 a.m.
The equity distribution agreement, filed as an 8-K with the Securities and Exchange Commission, allows Rocket Lab to sell shares periodically through a group of banks and brokerages acting as agents or principals. This at-the-market structure enables the company to gradually issue stock at prevailing market prices rather than executing a single large offering. The company stated that proceeds will be used to fund future growth initiatives, potential acquisitions, and general corporate and working capital needs. The filing also includes forward-sale provisions, where banks may borrow and sell shares as a hedge before Rocket Lab receives the proceeds or settles the transaction.
Rocket Lab's operating performance remains robust. The company reported first-quarter revenue of $200.3 million, a 63.5% increase year-over-year, along with a record backlog of $2.2 billion and over $2 billion in liquidity. Management guided second-quarter revenue in the range of $225 million to $240 million. However, the stock sale introduces dilution risk, as existing shareholders will own a smaller percentage of the company. Rocket Lab warned in the prospectus that sales under the program could depress the share price and dilute earnings per share if the proceeds do not generate sufficient returns.
The competitive landscape shifted dramatically with SpaceX's IPO filing on Wednesday. Reuters reported that SpaceX selected Nasdaq for its listing, marking a milestone for the private space giant. According to Investor's Business Daily, citing the prospectus, SpaceX generated $4.694 billion in revenue in the first quarter of 2026 and $18.674 billion for the full year 2025, with its Starlink satellite internet business driving a substantial portion. The scale difference between the two companies is stark, putting additional pressure on Rocket Lab's valuation.
MarketWatch noted that Rocket Lab fell more than 6% in after-hours trading following SpaceX's filing, while other space-related names such as Voyager Technologies and Firefly Aerospace also declined, albeit less sharply. Analyst reactions to SpaceX's IPO have been mixed. Dan Ives of Wedbush Securities characterized the IPO as placing SpaceX at the intersection of two major growth opportunities, while Dennis Dick of Triple D Trading expressed caution, calling a potential $2 trillion valuation "a little scary."
For Rocket Lab, the implications of the $3 billion stock sale are twofold. If investors view the program as prudent capital raising following a strong rally, the company gains additional resources for acquisitions, development of its Neutron rocket, and expansion of its defense-related business. Conversely, if the market perceives the offering as excessive stock issuance too soon, the shares could remain under pressure despite the company's growing backlog and solid revenue trajectory.
The timing of the filing, coinciding with SpaceX's IPO, amplifies the narrative of a space sector undergoing rapid evolution. Rocket Lab's ability to navigate this dual challenge of dilution concerns and heightened competitive scrutiny will be closely watched by investors in the coming weeks.
